Nanalysis Announces Third Quarter 2024 Conference Call
Nanalysis Scientific Corp (TSXV: NSCI, OTCQX: NSCIF) has scheduled its Third Quarter 2024 earnings conference call for Thursday, November 21st, 2024, at 5:00 PM ET. CEO Sean Krakiwsky and CFO Randall McRae will discuss results for the quarter ended September 30, 2024. Investors can join via phone (1-888-510-2154 or 289-819-1450 internationally) or through a webcast. A separate European Q&A session is scheduled for Friday, November 22nd at 8:30 AM ET. The webcast will be archived for 90 days, and a seven-day telephonic playback will be available.
Nanalysis Scientific Corp (TSXV: NSCI, OTCQX: NSCIF) ha programmato la sua conferenza telefonica sui risultati finanziari del terzo trimestre 2024 per giovedì 21 novembre 2024, alle 17:00 ET. Il CEO Sean Krakiwsky e il CFO Randall McRae discuteranno i risultati per il trimestre conclusosi il 30 settembre 2024. Gli investitori possono partecipare tramite telefono (1-888-510-2154 o 289-819-1450 a livello internazionale) o tramite un webcast. Una sessione di domande e risposte separata per l'Europa è programmata per venerdì 22 novembre alle 8:30 ET. Il webcast sarà archiviato per 90 giorni e sarà disponibile un playback telefonico per sette giorni.
Nanalysis Scientific Corp (TSXV: NSCI, OTCQX: NSCIF) ha programado su conferencia telefónica sobre los resultados del tercer trimestre de 2024 para el jueves 21 de noviembre de 2024, a las 17:00 ET. El CEO Sean Krakiwsky y el CFO Randall McRae discutirán los resultados del trimestre que terminó el 30 de septiembre de 2024. Los inversores pueden unirse por teléfono (1-888-510-2154 o 289-819-1450 internacionalmente) o a través de un webcast. Una sesión separada de preguntas y respuestas para Europa está programada para el viernes 22 de noviembre a las 8:30 ET. El webcast será archivado durante 90 días, y habrá una reproducción telefónica disponible durante siete días.
Nanalysis Scientific Corp (TSXV: NSCI, OTCQX: NSCIF)이 2024년 3분기 실적 회의를 2024년 11월 21일 목요일 오후 5시(ET)로 예정하였습니다. CEO Sean Krakiwsky와 CFO Randall McRae가 2024년 9월 30일로 종료된 분기의 결과에 대해 논의할 것입니다. 투자자들은 전화(1-888-510-2154 또는 국제전화 289-819-1450)나 웹캐스트를 통해 참여할 수 있습니다. 유럽을 위한 별도의 질의응답 세션은 11월 22일 금요일 오전 8시 30분(ET)으로 예정되어 있습니다. 웹캐스트는 90일 동안 아카이브될 것이며, 7일간 전화 재생이 가능합니다.
Nanalysis Scientific Corp (TSXV: NSCI, OTCQX: NSCIF) a programmé sa conférence téléphonique sur les résultats du troisième trimestre 2024 pour le jeudi 21 novembre 2024, à 17h00 ET. Le PDG Sean Krakiwsky et le directeur financier Randall McRae discuteront des résultats pour le trimestre se terminant le 30 septembre 2024. Les investisseurs peuvent se joindre par téléphone (1-888-510-2154 ou 289-819-1450 à l'international) ou via un webcast. Une session distincte de questions-réponses pour l'Europe est prévue pour le vendredi 22 novembre à 8h30 ET. Le webcast sera archivé pendant 90 jours, et une lecture téléphonique sera disponible pendant sept jours.
Nanalysis Scientific Corp (TSXV: NSCI, OTCQX: NSCIF) hat seinen Gewinnaufruf für das dritte Quartal 2024 auf Donnerstag, den 21. November 2024, um 17:00 Uhr ET angesetzt. CEO Sean Krakiwsky und CFO Randall McRae werden die Ergebnisse für das am 30. September 2024 abgelaufene Quartal erörtern. Anleger können über das Telefon (1-888-510-2154 oder international 289-819-1450) oder über ein Webcast teilnehmen. Eine separate Q&A-Sitzung für Europa ist für Freitag, den 22. November, um 8:30 Uhr ET geplant. Das Webcast wird für 90 Tage archiviert und es wird eine telefonische Wiedergabe für sieben Tage zur Verfügung stehen.
- None.
- None.
Hosting Call at 5:00 pm ET on Thursday, November 21st
European Q&A Session on Friday, November 22nd at 8:30am ET
Investors interested in participating in the live full year call can dial 1-888-510-2154 or 289-819-1450 from abroad. Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/qArLoq1oXkG on the investor relations section of the Company's website HERE.
The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-660-6345 or 289-819-1450, conference ID # 14204.
Additionally, the Company will be hosting a Q&A session for it's European investors at 8:30am ET on Friday, November 22nd which can be accessed by the following link: Join the meeting now.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced commercial compact NMR device ever brought to market.
The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally.
In 2022 the Company was awarded a five-year,
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-third-quarter-2024-conference-call-302298567.html
SOURCE Nanalysis Scientific Corp.
FAQ
When is Nanalysis Scientific (NSCIF) Q3 2024 earnings call?
How can investors join Nanalysis Scientific (NSCIF) Q3 2024 earnings call?